Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant chimeric monoclonal antibody against CD20

EU orphan designation number: EU/3/09/699   
Active ingredient: Recombinant chimeric monoclonal antibody against CD20
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: LFB-Biotechnologies
3 avenue des Tropiques BP 50052, Les Ulis, F-91942 Courtaboeuf CEDEX, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/12/2009 Centralised Orphan - Designation EMEA/OD/090/09 (2009)9603 of 26/11/2009
22/06/2010 Other procedure EMEA/OD/090/09